Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Physical and functional interaction between the HCMV IE2 protein and the Wilms' tumor suppressor WT1.

Kim JM, Hong Y, Semba K, Kim S.

Biochem Biophys Res Commun. 2000 Jan 7;267(1):59-63.

PMID:
10623574
4.

Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.

Borel F, Barilla KC, Hamilton TB, Iskandar M, Romaniuk PJ.

Biochemistry. 1996 Sep 17;35(37):12070-6.

PMID:
8810912
6.
8.

The human cytomegalovirus IE2 86 kDa protein elevates p53 levels and transactivates the p53 promoter in human fibroblasts.

Muganda P, Carrasco R, Qian Q.

Cell Mol Biol (Noisy-le-grand). 1998 Mar;44(2):321-31.

PMID:
9593583
9.

Human cytomegalovirus immediate-early protein IE2 tethers a transcriptional repression domain to p53.

Tsai HL, Kou GH, Chen SC, Wu CW, Lin YS.

J Biol Chem. 1996 Feb 16;271(7):3534-40.

10.

Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus.

Morris JF, Madden SL, Tournay OE, Cook DM, Sukhatme VP, Rauscher FJ 3rd.

Oncogene. 1991 Dec;6(12):2339-48.

PMID:
1662794
11.

HCMV IE2-mediated inhibition of HAT activity downregulates p53 function.

Hsu CH, Chang MD, Tai KY, Yang YT, Wang PS, Chen CJ, Wang YH, Lee SC, Wu CW, Juan LJ.

EMBO J. 2004 Jun 2;23(11):2269-80. Epub 2004 May 13.

12.

Inhibition of Wilms tumor 1 transactivation by bone marrow zinc finger 2, a novel transcriptional repressor.

Lee TH, Lwu S, Kim J, Pelletier J.

J Biol Chem. 2002 Nov 22;277(47):44826-37. Epub 2002 Sep 17.

13.
15.

EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.

Scharnhorst V, Menke AL, Attema J, Haneveld JK, Riteco N, van Steenbrugge GJ, van der Eb AJ, Jochemsen AG.

Oncogene. 2000 Feb 10;19(6):791-800.

17.

Negative regulation of a heterologous promoter by human cytomegalovirus immediate-early protein IE2.

Tsai HL, Kou GH, Tang FM, Wu CW, Lin YS.

Virology. 1997 Nov 24;238(2):372-9.

18.
19.

Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.

Cook DM, Hinkes MT, Bernfield M, Rauscher FJ 3rd.

Oncogene. 1996 Oct 17;13(8):1789-99.

PMID:
8895526
20.

WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein.

Wang ZY, Qiu QQ, Gurrieri M, Huang J, Deuel TF.

Oncogene. 1995 Mar 16;10(6):1243-7.

PMID:
7700651

Supplemental Content

Support Center